Background: An increased death risk is associated with acute respiratory distress
syndrome. For patients with advanced respiratory and circulatory problems,
ECMO provides temporary heart and lung replacement as well as breathing
support. This study aims to identify the outcomes and evaluate the findings of
recent studies involving ARDS patients receiving ECMO. Method: The PRISMA
guidelines were followed throughout the review. A thorough search of the
literature was done on Embase, Medline, PubMed Central, and PubMed. We next
screened the articles based on our inclusion criteria, and key terms. Results: In
this review, we considered eight trials with 3642 patients overall: one cohort
study, one randomized controlled trial, and six observational studies. Rates of
mortality showed notable variance. A number of variables surfaced as possible
predictors of the outcomes, including the age of the patient, the level of
hypoxemia, the degree of mechanical ventilation, comorbidities, and ECMOrelated
variables. Conclusion: Many factors, particularly those connected to the
patient, such as age, the degree of hypoxemia, and the cause of ARDS, can
explain the heterogeneity of outcomes. Mortality rates are also influenced by
ECMO-related issues, such as bleeding from anticoagulation, the development of
thrombocytopenia, and cannula-related problems.
Keywords: Outcome, extracorporeal membrane oxygenation, acute respiratory
distress
